Meyka AI API is live for developers.Start building.
Advertisement
Haleon plc

Haleon plc (HLN) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

HLNNYSE
HealthcareDrug Manufacturers - Specialty & Generic
$9.12
$0.16(1.79%)
U.S. Market opens in 50h 15m
Advertisement

Haleon plc (HLN)

Meyka AI Score

Z

Key Financials

Market Cap40.5B
P/E Ratio10.94
EPS (TTM)$0.50
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$8.60
3 Months$6.44
1 Year Target$10.00

HLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.94 and a market capitalization of 40.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.67%
5-Day Change
-0.55%
1-Month Change
-0.65%
3-Month Change
-11.81%
6-Month Change
-4.31%
Year-to-Date (YTD) Change
-9.89%
1-Year Change
-18.08%
3-Year Change
10.42%
5-Year Change
21.47%
All-Time (Max) Change
21.47%

Contact Information

44 1932 822000
Building 5, Weybridge, NaN, KT13 0NY

Company Facts

24,561 Employees
IPO DateJul 25, 2022
CountryGB
Actively Trading

Frequently Asked Questions